Loading your page…
Loading your page…
Osler answers from this library and names the guideline behind every claim.
This manuscript covers guidance proposed by The European Cystic Fibrosis Society Clinical Trials Network (ECFS-CTN) for the use of chest computed tomography (CT) scans in special situations such as haemoptysis, aspergillus-related lung disease, non-tuberculous mycobacterial (NTM) infection and pneumothorax in people with CF. Guidance development followed a three-step process. The most important questions were first identified via anonymous online survey, then a comprehensive literature search was made to support a first set of statements. They were finally validated by a Delphi process to obtain collective opinion of participants. Consensus supported the use of chest CT in the presence of haemoptysis, Allergic Bronchopulmonary Aspergillosis, and NTM-positive cultures (>2 separate expectorated sputum samples, or 1 positive bronchoscopic result). The ultimate responsibility for justifying a chest CT scan lies with the healthcare professionals directly involved in patient management.
Published by Respiratory medicine, 2026. The PDF is shown as published and remains the work of its authors and publisher; the original is at the source linked here. Rights holders can ask us to remove a file at info@prognia.nl.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
